Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Phase I/II Study of EOS884448 (EOS-448) in Combination With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors

NCT05060432 is registered in ClinicalTrials.gov with iTeos Belgium SA as lead sponsor.

NCT NCT05060432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Phase I/II Study of EOS884448 (EOS-448) in Combination With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
Lead sponsor
iTeos Belgium SA
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 6, 2021
Completion date
July 31, 2025
Enrollment
153 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, head and neck cancer, lung cancer, melanoma